I. E. Smith

1.1k total citations
27 papers, 848 citations indexed

About

I. E. Smith is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, I. E. Smith has authored 27 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Cancer Research and 9 papers in Genetics. Recurrent topics in I. E. Smith's work include Breast Cancer Treatment Studies (12 papers), Estrogen and related hormone effects (9 papers) and Cancer Treatment and Pharmacology (7 papers). I. E. Smith is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Estrogen and related hormone effects (9 papers) and Cancer Treatment and Pharmacology (7 papers). I. E. Smith collaborates with scholars based in United Kingdom, United States and Canada. I. E. Smith's co-authors include Sunil R. Lakhani, Jorge S. Reis‐Filho, Susana Banerjee, S. Ashley, Lara Lipton, D Steele, A. Ashworth, Janine Salter, Martin Gore and Mitch Dowsett and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

I. E. Smith

26 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. E. Smith United Kingdom 12 503 403 217 200 137 27 848
S. Ashley United Kingdom 9 772 1.5× 432 1.1× 234 1.1× 331 1.7× 185 1.4× 12 1.1k
A McKinna United Kingdom 11 407 0.8× 232 0.6× 255 1.2× 210 1.1× 125 0.9× 14 756
Takaomi Suzuma Japan 17 306 0.6× 256 0.6× 358 1.6× 185 0.9× 160 1.2× 52 885
R Bettelheim United Kingdom 9 435 0.9× 233 0.6× 174 0.8× 90 0.5× 134 1.0× 12 724
E. Bourstyn France 12 503 1.0× 637 1.6× 228 1.1× 156 0.8× 358 2.6× 30 1.1k
K. Mehta Germany 14 809 1.6× 669 1.7× 103 0.5× 145 0.7× 277 2.0× 28 1.1k
Morihiko Kimura Japan 16 349 0.7× 204 0.5× 191 0.9× 145 0.7× 104 0.8× 47 698
R.S. Rampaul United Kingdom 14 431 0.9× 358 0.9× 236 1.1× 132 0.7× 276 2.0× 33 905
Volker Moebus Germany 15 393 0.8× 224 0.6× 164 0.8× 82 0.4× 78 0.6× 52 705
J. Carmichael United Kingdom 16 635 1.3× 178 0.4× 299 1.4× 188 0.9× 128 0.9× 24 987

Countries citing papers authored by I. E. Smith

Since Specialization
Citations

This map shows the geographic impact of I. E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. E. Smith more than expected).

Fields of papers citing papers by I. E. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. E. Smith. The network helps show where I. E. Smith may publish in the future.

Co-authorship network of co-authors of I. E. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of I. E. Smith. A scholar is included among the top collaborators of I. E. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. E. Smith. I. E. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García-Murillas, Isaac, Charles W. Abbott, Rosalind Cutts, et al.. (2025). Whole genome sequencing-powered ctDNA sequencing for breast cancer detection. Annals of Oncology. 36(6). 673–681. 10 indexed citations
2.
Tang, Sarah, Ashutosh Nerurkar, Peter Osin, et al.. (2018). Complete excision with narrow margins provides equivalent local control to wider excision in breast conservation for invasive cancer. BJS Open. 3(2). 161–168. 4 indexed citations
3.
Dowsett, Mitch, I. E. Smith, John Robertson, et al.. (2011). Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast Cancer. JNCI Monographs. 2011(43). 120–123. 53 indexed citations
4.
Coleman, Robert E., Gianfilippo Bertelli, I.H. Kunkler, et al.. (2011). UK Guidance Document: Treatment of Metastatic Breast Cancer. Clinical Oncology. 24(3). 169–176. 8 indexed citations
5.
Arnedos, Mónica, Roberta Ferraldeschi, Roger A’Hern, et al.. (2011). Polymorphisms of the aromatase gene (CYP19A1) and benefit of aromatase inhibitors (AIs) in metastatic breast cancer (mBC) patients.. Journal of Clinical Oncology. 29(15_suppl). 608–608. 1 indexed citations
6.
Pierga, J-Y, K. I. Pritchard, Christoph Thomssen, et al.. (2009). Safety and efficacy of first-line bevacizumab (B) plus chemotherapy (CT) for locally recurrent or metastatic breast cancer (LR/mBC): Analysis of MO19391 according to CT. Journal of Clinical Oncology. 27(15_suppl). 1033–1033. 6 indexed citations
7.
Sirohi, Bhawna, Mónica Arnedos, Sanjay Popat, et al.. (2008). Platinum-based chemotherapy in triple-negative (TN) breast cancer. Journal of Clinical Oncology. 26(15_suppl). 1051–1051. 1 indexed citations
8.
Banerjee, Susana, Jorge S. Reis‐Filho, S. Ashley, et al.. (2006). Basal-like breast carcinomas: clinical outcome and response to chemotherapy. Journal of Clinical Pathology. 59(7). 729–735. 234 indexed citations
9.
Dowsett, M, S. Johnston, Janine Salter, et al.. (2005). Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience. Endocrine Related Cancer. 12(Supplement_1). S113–S117. 33 indexed citations
10.
Ring, Alexander, Peter Ellis, A. Jones, et al.. (2004). Chemotherapy for breast cancer given during pregnancy: A case serie. Journal of Clinical Oncology. 22(14_suppl). 715–715. 1 indexed citations
11.
Dowsett, Mitch, Catherine Harper‐Wynne, Irene Boeddinghaus, et al.. (2001). HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.. PubMed. 61(23). 8452–8. 150 indexed citations
12.
Smith, I. E.. (2001). Efficacy and safety of Herceptin® in women with metastatic breast cancer: results from pivotal clinical studies. Anti-Cancer Drugs. 12. S3–S10. 70 indexed citations
13.
Smith, I. E. & Lara Lipton. (2001). Preoperative/neoadjuvant medical therapy for early breast cancer. The Lancet Oncology. 2(9). 561–570. 66 indexed citations
14.
Smith, I. E., Geoffrey Falkson, Renaud Léonard, et al.. (1996). PP-8-3 Double-blind trial in postmenopausal (PMP) women with advanced breast cancer (ABC) showing a dose-effect and superiority of 2.5 mg letrozole over megestrol acetate (MA). European Journal of Cancer. 32. 49–49. 11 indexed citations
15.
Smith, I. E., et al.. (1990). A randomized study to determine complications associated with duration of insertion of Heparin locks. Research in Nursing & Health. 13(6). 367–373. 22 indexed citations
16.
Gore, Martin, A. Hilary Calvert, & I. E. Smith. (1987). High dose carboplatin in the treatment of lung cancer and mesotherlioma: a phase I dose escalation study. European Journal of Cancer and Clinical Oncology. 23(9). 1391–1397. 58 indexed citations
17.
Pérez, David, T.J. Powles, I. E. Smith, et al.. (1985). The modulating effects of flurbiprofen on adriamycin plus vincristine or vindesine in the treatment of advanced breast cancer. Cancer Chemotherapy and Pharmacology. 15(3). 278–82. 2 indexed citations
18.
Smith, I. E., R Powles, Hugh M. Clink, et al.. (1977). Early deaths in acute myelogenous leukemia. Cancer. 39(4). 1710–1714. 18 indexed citations
19.
Smith, I. E., H.B. Eckstein, Jordan N. Kohn, & T J McElwain. (1977). Metastatic Orchioblastoma: Alpha 1 ‐fetoprotein in Diagnosis and Combination Chemotherapy in Treatment: a Case Report. British Journal of Urology. 49(5). 427–430. 2 indexed citations
20.
Smith, I. E., Hugh M. Clink, Michael Gerken, & T J McElwain. (1976). VP 16-213 in acute myelogenous leukaemia. Postgraduate Medical Journal. 52(604). 66–70. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Ashley Breakdown of academic impact, for papers by A McKinna Breakdown of academic impact, for papers by Takaomi Suzuma Breakdown of academic impact, for papers by R Bettelheim Breakdown of academic impact, for papers by E. Bourstyn Breakdown of academic impact, for papers by K. Mehta Breakdown of academic impact, for papers by Morihiko Kimura Breakdown of academic impact, for papers by R.S. Rampaul Breakdown of academic impact, for papers by Volker Moebus Breakdown of academic impact, for papers by J. Carmichael
Rankless by CCL
2026